XML 74 R5.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY Statement - USD ($)
shares in Thousands, $ in Thousands
Total
Common stock [Member]
Treasury stock [Member]
Additional paid-in capital [Member]
Retained earnings [Member]
Stockholders' equity, beginning of period at Dec. 31, 2016 $ 680,601 $ 668 $ (2,529) $ 649,280 $ 33,182
Stockholders' Equity [Abstract]          
Exercise of stock options 3,396 3   3,393  
Shares vested for long-term incentive plan 0 2   (2)  
Repurchases of common stock related to equity award activity (1,292)   (1,292)    
Stock compensation expense 6,769     6,769  
Net income 57,425       57,425
Stockholders' equity, end of period at Dec. 31, 2017 746,899 $ 673 $ (3,821) 659,440 90,607
Common stock outstanding, beginning of period (in shares) at Dec. 31, 2016   66,814      
Treasury shares, beginning of period (in shares) at Dec. 31, 2016     148    
Stockholders Equity, Common Shares [Abstract]          
Exercise of stock options (in shares)   260      
Shares vested for long-term incentive plan   212      
Repurchases of common stock related to equity award activity (in shares)     59    
Common stock outstanding, end of period (in shares) at Dec. 31, 2017   67,286      
Treasury shares, end of period (in shares) at Dec. 31, 2017     207    
Stockholders' Equity [Abstract]          
Exercise of stock options 1,327 $ 1   1,326  
Shares vested for long-term incentive plan 0 3   (3)  
Repurchases of common stock under share repurchase program (2,891)   $ (2,891)    
Repurchases of common stock related to equity award activity (1,729)   (1,729)    
Share withholdings made in satisfaction of exercise price 0   17 (17)  
Stock compensation expense 11,315     11,315  
Net income 119,738       119,738
Stockholders' equity, end of period at Dec. 31, 2018 $ 874,659 $ 677 $ (8,458) 672,095 210,345
Stockholders Equity, Common Shares [Abstract]          
Exercise of stock options (in shares)   96      
Shares vested for long-term incentive plan   326      
Repurchases of common stock under share repurchase program (in shares)     182    
Repurchases of common stock related to equity award activity (in shares)     88    
Share withholdings made in satisfaction of exercise price (shares)     1    
Common stock outstanding, end of period (in shares) at Dec. 31, 2018 67,200 67,708      
Treasury shares, end of period (in shares) at Dec. 31, 2018 500   478    
Stockholders' Equity [Abstract]          
Exercise of stock options $ 2,704 $ 2   2,702  
Shares vested for long-term incentive plan 0 4   (4)  
Repurchases of common stock under share repurchase program (16,446)   $ (16,446)    
Repurchases of common stock related to equity award activity (1,712)   (1,712)    
Stock compensation expense 12,462     12,462  
Net income 109,845       109,845
Stockholders' equity, end of period at Dec. 31, 2019 $ 981,512 $ 683 $ (26,616) $ 687,255 $ 320,190
Stockholders Equity, Common Shares [Abstract]          
Exercise of stock options (in shares)   199      
Shares vested for long-term incentive plan   399      
Repurchases of common stock under share repurchase program (in shares)     961    
Repurchases of common stock related to equity award activity (in shares)     89    
Common stock outstanding, end of period (in shares) at Dec. 31, 2019 66,800 68,306      
Treasury shares, end of period (in shares) at Dec. 31, 2019 1,500   1,528